← Back to Search

Nicotine Pouches

Product usage order AIBHCGDFE for Tobacco Use

N/A
Waitlist Available
Led By Debra Kelsh, MD
Research Sponsored by British American Tobacco (Investments) Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 minutes
Awards & highlights

Study Summary

This study is evaluating whether nicotine replacement therapy may help reduce the urge to smoke.

Eligible Conditions
  • Tobacco Use
  • Tobacco Smoking

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 180 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AUCnic 0-180 mins
Cmax

Trial Design

18Treatment groups
Experimental Treatment
Group I: Product usage order IHAGBFCEDExperimental Treatment9 Interventions
Subjects will use each of the 9 products (IHAGBFCED) during a familiarization period, followed by a 3 hour Test Session
Group II: Product usage order IAHBGCFDEExperimental Treatment9 Interventions
Subjects will use each of the 9 products (IAHBGCFDE) during a familiarization period, followed by a 3 hour Test Session
Group III: Product usage order HIGAFBECDExperimental Treatment9 Interventions
Subjects will use each of the 9 products (HIGAFBECD) during a familiarization period, followed by a 3 hour Test Session
Group IV: Product usage order HGIFAEBDCExperimental Treatment9 Interventions
Subjects will use each of the 9 products (HGIFAEBDC) during a familiarization period, followed by a 3 hour Test Session
Group V: Product usage order GHFIEADBCExperimental Treatment9 Interventions
Subjects will use each of the 9 products (GHFIEADBC) during a familiarization period, followed by a 3 hour Test Session
Group VI: Product usage order GFHEIDACBExperimental Treatment9 Interventions
Subjects will use each of the 9 products (GFHEIDACB) during a familiarization period, followed by a 3 hour Test Session
Group VII: Product usage order FGEHDICABExperimental Treatment9 Interventions
Subjects will use each of the 9 products (FGEHDICAB) during a familiarization period, followed by a 3 hour Test Session
Group VIII: Product usage order FEGDHCIBAExperimental Treatment9 Interventions
Subjects will use each of the 9 products (FEGDHCIBA) during a familiarization period, followed by a 3 hour Test Session
Group IX: Product usage order EFDGCHBIAExperimental Treatment9 Interventions
Subjects will use each of the 9 products (EFDGCHBIA) during a familiarization period, followed by a 3 hour Test Session
Group X: Product usage order EDFCGBHAIExperimental Treatment9 Interventions
Subjects will use each of the 9 products (EDFCGBHAI) during a familiarization period, followed by a 3 hour Test Session
Group XI: Product usage order DECFBGAHIExperimental Treatment9 Interventions
Subjects will use each of the 9 products (DECFBGAHI) during a familiarization period, followed by a 3 hour Test Session
Group XII: Product usage order DCEBFAGIHExperimental Treatment9 Interventions
Subjects will use each of the 9 products (DCEBFAGIH) during a familiarization period, followed by a 3 hour Test Session
Group XIII: Product usage order CDBEAFIGHExperimental Treatment9 Interventions
Subjects will use each of the 9 products (CDBEAFIGH) during a familiarization period, followed by a 3 hour Test Session
Group XIV: Product usage order CBDAEIFHGExperimental Treatment9 Interventions
Subjects will use each of the 9 products (CBDAEIFHG) during a familiarization period, followed by a 3 hour Test Session
Group XV: Product usage order BCADIEHFGExperimental Treatment9 Interventions
Subjects will use each of the 9 products (BCADIEHFG) during a familiarization period, followed by a 3 hour Test Session
Group XVI: Product usage order BACIDHEGFExperimental Treatment9 Interventions
Subjects will use each of the 9 products (BACIDHEGF) during a familiarization period, followed by a 3 hour Test Session
Group XVII: Product usage order AIBHCGDFEExperimental Treatment9 Interventions
Subjects will use each of the 9 products (AIBHCGDFE) during a familiarization period, followed by a 3 hour Test Session
Group XVIII: Product usage order ABICHDGEFExperimental Treatment9 Interventions
Subjects will use each of the 9 products (ABICHDGEF) during a familiarization period, followed by a 3 hour Test Session

Find a Location

Who is running the clinical trial?

British American Tobacco (Investments) LimitedLead Sponsor
5 Previous Clinical Trials
918 Total Patients Enrolled
2 Trials studying Tobacco Use
842 Patients Enrolled for Tobacco Use
Debra Kelsh, MDPrincipal InvestigatorAltasciences Clinical Kansas, Inc.
12 Previous Clinical Trials
514 Total Patients Enrolled
3 Trials studying Tobacco Use
157 Patients Enrolled for Tobacco Use

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Study to Characterize Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouches in Adult Cigarette Smokers
2021. "A Study to Characterize Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouches in Adult Cigarette Smokers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04846088.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top